HeyJaredVictoria Forster
- Indexed articles, last 90 days
- 2
- Latest publication
- Aug 25, 2026
- Outlet visibility, for Cancer Therapy Advisor
- Top 5M sites
- Earliest in this view
- Aug 24, 2026
Latest articles
The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors - Oncology Nurse Advisor (opens the original)
Read excerpt
In May 2001, the US Food and Drug Administration (FDA) granted accelerated approval to the small molecule targeted cancer drug imatinib (Gleevec) for the treatment of chronic myeloid leukemia (CML).1 The drug had shown unprecedented results in its early trials, with a significant proportion of patients achieving complete hematologic responses.2-5 Nothing short of miraculous for a disease where previously less than 50% of people survived 5 years or more after diagnosis.2 Time magazine heralded it
The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors (opens the original)
Read excerpt
In May 2001, the US Food and Drug Administration (FDA) granted accelerated approval to the small molecule targeted cancer drug imatinib (Gleevec) for the treatment of chronic myeloid leukemia (CML).1 The drug had shown unprecedented results in its early trials, with a significant proportion of patients achieving complete hematologic responses.2-5 Nothing short of miraculous for a disease where previously less than 50% of people survived 5 years or more after diagnosis.2 Time magazine heralded it
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Cancer Therapy Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.